View in EDS HTML Full Text PDF Full Text

Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.

Saved in:
Bibliographic Details
Title: Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.
Authors: Nehme, Jamil1 (AUTHOR), Maassen, Sjors1 (AUTHOR), Bravaccini, Sara2 (AUTHOR), Zanoni, Michele2 (AUTHOR), Gianni, Caterina2 (AUTHOR), De Giorgi, Ugo2 (AUTHOR), Soto-Gamez, Abel1 (AUTHOR), Altulea, Abdullah1 (AUTHOR), Gheorghe, Teodora1 (AUTHOR), Wang, Boshi1 (AUTHOR) b.wang01@umcg.nl, Demaria, Marco1 (AUTHOR) m.demaria@umcg.nl
Source: EMBO Journal. Apr2025, Vol. 44 Issue 7, p1921-1942. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02614189
DOI:10.1038/s44318-025-00371-x